Filter
5402
Filtered Results: 5402
Text search:
health
policy
and
programs
Featured
Recommendations
324
New Publications
1582
Language
Document type
No document type
3315
Studies & Reports
940
Guidelines
494
Manuals
251
Strategic & Response Plan
187
Training Material
83
Fact sheets
70
Situation Updates
28
Resource Platforms
16
Infographics
7
Online Courses
4
Brochures
3
Dashboards/Maps
2
App
1
Videos
1
Countries / Regions
Kenya
229
India
205
Global
199
Ethiopia
175
Nepal
151
Uganda
145
Malawi
115
Liberia
114
Nigeria
109
Rwanda
107
South Africa
105
Sierra Leone
100
Zambia
99
Myanmar / Burma
98
Bangladesh
95
Latin America and the Carribbean
94
Tanzania
92
Ghana
76
Africa
73
Western and Central Europe
68
Philippines
62
Indonesia
62
Ukraine
59
Zimbabwe
51
Namibia
50
Syria
48
Cambodia
47
Lesotho
46
Asia
43
Senegal
42
Eastern Europe
40
Mozambique
34
Haiti
33
Congo, Democratic Republic of
32
South–East Asia Region
29
Guinea
27
Cameroon
24
South Sudan
24
West and Central Africa
24
Russia
24
Eswatini/ Swaziland
23
Burkina Faso
22
Botswana
22
Pakistan
20
Afghanistan
20
East and Southern Africa
20
Venezuela
19
Thailand
18
Middle East and North Africa
18
Brazil
17
Colombia
16
Jordan
15
Lebanon
15
Benin
13
Sudan
12
Central African Republic
12
Tajikistan
12
USA
11
Yemen
11
Mali
10
Albania
10
Vietnam
10
Somalia
9
Germany
9
Peru
9
Western Pacific Region
9
Paraguay
9
Georgia
9
China
8
Mexico
8
Sri Lanka
8
Papua New Guinea
7
Argentina
7
Eastern Europe and Central Asia
7
Laos
7
Moldova
7
Iraq
6
Turkey
6
Chile
6
North America
6
Egypt
5
North Macedonia
5
Hungary
5
Burundi
5
Bhutan
5
Armenia
5
Côte d’Ivoire / Ivory Coast
4
Niger
4
Ecuador
4
Bolivia
4
Libya
4
Angola
4
Poland
4
Palestine
4
Canada
4
Timor Leste/ East Timor
4
Romania
4
Iran
4
Kyrgyzstan
4
Guinea-Bissau
3
Honduras
3
Greece
3
Madagascar
3
Fiji
3
Jamaica
3
Saudi Arabia
2
Togo
2
Chad
2
Gambia
2
Malaysia
2
Singapore
2
Croatia
2
El Salvador
2
Guatemala
2
Italy
2
Southern Africa
2
Estonia
2
Slovakia
2
Kazakhstan
2
Turkmenistan
2
Japan
2
Belarus
2
Morocco
1
Dominican Republic
1
Nicaragua
1
North Korea
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Uzbekistan
1
Belgium
1
Maldives
1
United Kingdom
1
Norway
1
Portugal
1
Azerbaijan
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2388
Public Health
303
Women & Child Health
277
Clinical Guidelines
273
Key Resources
226
Capacity Building
78
Pharmacy & Technologies
31
Protection & Security
2
Annual Report MEDBOX
1
Toolboxes
HIV
459
Mental Health
386
COVID-19
295
TB
291
Planetary Health
239
Disability
223
AMR
158
Caregiver
158
Conflict
118
Global Health Education
100
NCDs
97
Rapid Response
91
Pharmacy
83
NTDs
83
Ebola
75
Refugee
72
Health Financing Toolbox
66
Natural Hazards
53
Polio
26
Specific Hazards
26
Social Ethics
23
Zika
13
Cholera
11
Health Financing
2
South Sudan
1
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being prevent...
This document sets out the criteria and procedures to be followed by countries in verifying the interruption of yaws transmission. It is intended for use by international verification teams, national yaws eradication ...mes and WHO technical staff involved in the eradication of yaws.
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) ... the Model List of Essential Medicine for Children (EMLc).
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and formulation on the Model Lists of Essential Medicines. The Committee evaluated the scientific evidence for comparative effectiveness, safety and cost-effectiveness of the medicines in question. The Committee also considered a review of the therapeutic alternatives for medicines on the Model Lists, and update to the AWaRe classification of antibiotics, and reviews and reports relevant to the selection and use of essential medicines.
The global burden of disease associated with air pollution exposure exacts a massive toll on human health worldwide: exposure to air pollution is estimated to cause millions of deaths and lost years...
Updated Guideline.
The Emergency Triage Assessment and Treatment (ETAT) guidelines provide guidance on the most common emergency conditions in children presenting at the health facility. These incl...
The WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks.
High quality of care in family planning (FP) services has been found to be associated with increased and continued use of contraceptive methods. The interpersonal skills and technical competence of ...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft G...
Quality of care in fragile, conflict-affected and vulnerable settings: tools and resources compendium
recommended
This compendium represents a curated, pragmatic and non-prescriptive collection of tools and resources to support the implementation of interventions to improve quality of care in such contexts. Rel...
This report presents country, regional and global estimates of low birth weight for 2000, together with a detailed description of the methods used in calculating the estimates. Some limited data on trends are also included. The limitations of low-bi...
Investigación original / Original research
Panam Salud Publica. 2016;39(1):38–43.
The way we talk about global issues affects how people think, feel and react to them. Recognising that language has the power to create social change, we have produced this guide with the inten-tion of setting out a different approach to communicati...
The COVID-19 Strategic Preparedness and Response Plan (SPRP) 2021 Monitoring and Evaluation Framework tracks global progress against the COVID-19 SPRP 2021 for the ten pillars of the public ... response. The operational intelligence complements the epidemiologic information used to drive a global dynamic system of support and response. Monitoring SPRP 2021 implementation will support countries, partners and WHO in strategic thinking, operational tracking and course correction based on evidence and transparency to strengthen the response to COVID-19.
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying ... managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisectoral population-based interventions to reduce CVD risk factors in the entire population.
Methods: We describe key public health considerations in identifying and managing individuals at high risk of CVD in LMICs.
Results: A main objective of any strategy to identify individuals at high CVD risk is to maximize the number of CVD events averted while minimizing the numbers of
individuals needing treatment. Scores estimating the total risk of CVD (e.g. ten-year risk of fatal and non-fatal CVD) are available for LMICs, and are based on the main CVD risk factors (history of CVD, age, sex, tobacco use, blood pressure, blood cholesterol and diabetes status). Opportunistic screening of CVD risk factors enables identification of persons with high CVD risk, but this strategy can be widely applied in low resource settings only if cost effective interventions are used (e.g. the WHO Package of Essential NCD interventions for primary health care in low resource settings package) and if treatment (generally for years) can be sustained, including continued availability ofaffordable medications and funding mechanisms that allow people to purchase medications without impoverishing them (e.g. universal access to health care). Thisalso emphasises the need to re-orient health systems in LMICs towards chronic diseases management.
Conclusion: The large burden of CVD in LMICs and the fact that persons with high
CVD can be identified and managed along cost-effective interventions mean that
health systems need to be structured in a way that encourages patient registration, opportunistic screening of CVD risk factors, efficient procedures for the management of chronic conditions (e.g. task sharing) and provision of affordable treatment for those with high CVD risk. The focus needs to be in primary care because that is where most of the population can access health care and because CVD programmes can be run effectively at this level.
